Biologic characteristics of rat bone marrow mesenchymal stem cells cultured in vitro

Chinese Journal of Pathology

Volumn 36, Issue 8, 2007, Pages 550-554

  Yu, Xiao Xia ^a   Shi, Ying Ai ^a   Xin, Ying ^a   Zhang, Li Hong ^a   Li, Yu Lin ^a   Wu, Shan ^a  

^a JILIN UNIVERSITY   (China)

Author keywords

Biological marker; Cell cycle; Mesenchymal stem cell; Telomerase

Indexed keywords

BETA1 INTEGRIN; BIOLOGICAL MARKER; TELOMERASE; THY 1 ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; BIOLOGICAL TRAIT; BONE MARROW; CELL CYCLE; CELL GROWTH; CONTROLLED STUDY; DENSITY GRADIENT CENTRIFUGATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNOPHENOTYPING; IN VITRO STUDY; MESENCHYMAL STEM CELL; NONHUMAN; RAT; TELOMERIC REPEAT AMPLIFICATION PROTOCOL;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD29; ANTIGENS, THY-1; BONE MARROW CELLS; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; IMMUNOPHENOTYPING; MALE; MESENCHYMAL STEM CELLS; RATS; RECEPTORS, TRANSFERRIN;

EID: 34848847184     PISSN: 05295807     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science,1999,284 (5411):143-147.
2. Banfi A, Muraglia A, Dozin B, et al. Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: implications for their use in cell therapy. Exp Hematol,2000,28(6):707-715.
3. Donald P, Arnold I. Isolation of rat marrow-derived mesenchymal stem cells. Exp Hematol,2006,34(11):1606-1607.
4. Sugiura F, Kitoh H, Ishiguro N. Osteogenic potential of rat mesenchymal stem cells after several passages. Biochem Biophys Res Commun,2004, 316(1):233-239.
5. Chinese source
6. Chinese source
7. Scorsin M, Hagege AA, Vilquin JT, et al. Comparison of the effects of fetal cardiomyocyte and skeletal myoblast transplantation on postinfarction left ventricular function. Thorac Cardiovasc Surg, 2000,119(6):1169-1175.
8. Deans RJ, Moseley AB. Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol,2000,28(8):875-884.
9. Rubio D, Garcia-Castro J, Maria MC, et al. Spontaneous human adult stem cell transformation. Cancer Res,2005,65(8):3035-3039.
10. Barry FP. Mesenchynal stem cell therapy in joint disease. Novartis Found Symp,2003,249:86-96.
11. Wagner W, Wein F, Seckinger A, et al. Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Exp Hematol,2005,33(11): 1402-1416.
12. Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and Cancer. Science, 1994,266(23):2011-2015.
13. Chinese source
14. Epel ES, Blackburn EH, Lin J, et al. Accelerated telomere shortening in response to life stress. Proc Natl Acad Sci U S A, 2004,101(49):17312-17315.
15. Allsopp RC, Chang E, Kashefi-Aazam M, et al. Telomere shortening is associated with cell division in vitro and in vivo. Exp Cell Res,1995,220(1):194-220.
16. Bodnar AG, Ouellette M, Frolkis M, et al. Extension of life-span by introduction of telomerase into normal human cells. Science,1998, 279(5349):349-352.
17. Chinese source